WASHINGTON, Nov. 12, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the following upcoming investor conferences in November ...

HC Wainwright initiated coverage on Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), a commercial-stage biopharmaceutical firm ...

当上特朗普的榜一大哥后，马斯克的特斯拉能重新成为散户最爱的股票吗？这可能取决于英伟达。近期，特斯拉的散户交易量有所反弹，选举之夜成为交易最多的股票之一，但是，英伟达仍然是散户购买最多的股票，未来这种情况是否会持续，不仅取决于特斯拉的表现，也取决于英伟 ...

H.C. Wainwright initiated coverage of Vanda Pharmaceuticals (NASDAQ:VNDA) with a buy rating, citing its negative enterprise ...

英为财情Investing.com - Vanda Pharmaceuticals (NASDAQ: VNDA )星期三发布了第三季度的财报，数据显示，公司营收逊于分析师的预期，每股收益超出了分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.09，总营收为$47.7M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$50.75M，每股收益为$-0 ...

Vanda Pharmaceuticals ( (VNDA) ) has released its Q3 earnings. Here is a breakdown of the information Vanda Pharmaceuticals presented to its ...

The FDA’s rejection of Vanda Pharmaceuticals’ stomach disease candidate has done little to dampen the enthusiasm of England’s Cycle Pharmaceuticals to acquire the Washington D.C.-based company.

Cantor Fitzgerald analyst Charles Duncan maintained a Buy rating on Vanda (VNDA – Research Report) today and set a price target of $13.00. The company’s shares closed yesterday at $4.89. Duncan covers ...

H.C. Wainwright initiated coverage of Vanda Pharmaceuticals (NASDAQ:VNDA) with a buy rating, citing its negative enterprise value. The investment bank said its rating was based on Vanda’s well ...

HC Wainwright sets an $18 target on Vanda Pharmaceuticals amid a 30% discount to cash reserves. Vanda's portfolio could reach key clinical and regulatory milestones within 6–18 months.

WASHINGTON (AP) — WASHINGTON (AP) — Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported a loss of $5.3 million in its third quarter. The Washington-based company said it had a loss of 9 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...